Last reviewed · How we verify

NCT05901805

Validation of the Occupational Sitting and Physical Activity Questionnaire for E-Sports Players

Status unknown Last updated 13 June 2023
What this trial tests

trial testing questionnaire application in Physical Inactivity in 30 participants. Status unknown.

Timeline
1 September 2023
Primary endpoint
1 December 2023
1 December 2023

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 September 2023
Primary completion1 December 2023
Estimated completion1 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 12 to 24, any sex, with Physical Inactivity or Sedentary Time. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Electronic sports (Esports) has become a branch that started to gain popularity in the gaming community in the early 2000s and that more and more individuals are interested in. Esports players are often called sedentary athletes because gaming requires prolonged sedentary activity. The aim of this study is to adapt the Occupational Sitting and Physical Activity Questionnaire to individuals playing Esports and to validate it in Turkish.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionnaire application

Trials testing the same drug.

Other recruiting trials for Physical Inactivity

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05901805.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing